Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus
Condition(s):NAFLD; Type 1 Diabetes; Cardiovascular DiseasesLast Updated:March 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):NAFLD; Type 1 Diabetes; Cardiovascular DiseasesLast Updated:March 4, 2022Recruiting
Condition(s):Morbid Obesity; NAFLDLast Updated:October 1, 2015Completed
Condition(s):Diabetes Mellitus; Non-alcoholic Fatty Liver Disease; Metabolic Syndrome; ObesityLast Updated:February 11, 2021Unknown status
Condition(s):Obesity; Non-Alcoholic Fatty Liver Disease; Insulin ResistanceLast Updated:September 29, 2023Recruiting
Condition(s):Non Alcoholic Steatohepatitis (NASH)Last Updated:October 17, 2023Terminated
Condition(s):Nonalcoholic SteatohepatitisLast Updated:January 12, 2009Completed
Condition(s):Cardiovascular Diseases; Lipid Disorder; Metabolic Disease; Non-Alcoholic Fatty Liver DiseaseLast Updated:March 6, 2023Active, not recruiting
Condition(s):Obesity, Morbid; Obesity; NAFLD; NASH – Nonalcoholic SteatohepatitisLast Updated:March 22, 2018Unknown status
Condition(s):Fatty Liver, Nonalcoholic; Diabetes Mellitus, Type 2Last Updated:July 25, 2022Active, not recruiting
Condition(s):Non-alcoholic Fatty Liver Disease; Obesity; Metabolic SyndromeLast Updated:April 1, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.